Net income of ChemoCentryx under GAAP for 2021 was $131.755 million, up 2.4 times from $55.356 million in the previous year. Revenues halved to $32.224 million from $64.891 million a year earlier.
Net income of ChemoCentryx under GAAP for 2021 was $131.755 million, up 2.4 times from $55.356 million in the previous year. Revenues halved to $32.224 million from $64.891 million a year earlier. 
ir.chemocentryx.com
English (US) 